Hyperprogression under treatment with immune-checkpoint inhibitors in patients with gastrointestinal cancer: A natural process of advanced tumor progression?

World J Clin Oncol. 2022 Sep 24;13(9):729-737. doi: 10.5306/wjco.v13.i9.729.

Abstract

Immunotherapy has shown great promise in treating various types of malignant tumors. However, some patients with gastrointestinal cancer have been known to experience rapid disease progression after treatment, a situation referred to as hyperprogressive disease (HPD). This minireview focuses on the definitions and potential mechanisms of HPD, natural disease progression in gastrointestinal malignancies, and tumor immunological microenvironment.

Keywords: Colorectal cancer; Gastric cancer; Hyperprogressive; Immunotherapy; Natural process.

Publication types

  • Review